Preliminary program

07:30

08:00 – 09:30

Plenary Room A

• The role of imaging in the decision – Mathew Leonardi (Canada)
• When and how the cystectomy? Kaori Koga (Japan)
• Hysteroscopic management of FIGO 3 fibroids: real option or boldness? Lubomir Mikulasek (Czech Republic)
• Place of vaginal radiofrequency ablation in uterine disorders – Ángel Santalla Hernández (Spain)

09:30 – 10:00
Exhibition Hall

10:00 – 12:30

10:00 – 12:30
Salle 241

Free Communications 1

• Longitudinal Ultrasound Evaluation of Cesarean Section Scar Changes Over Six Months – Elham Askary (Iran)
• Endometriosis-associated Ovarian Cancer, from Risk Factors to Survival Rate: A Systematic Review and Meta-Analysis – Elham Askary (Iran)
• MRI for endometriosis: ESUR Consensus for indications, reporting and classifications – Isabelle Thomassin-Naggara (France)
• MRI for endometriosis: ESUR Consensus for protocol and lexicon – Isabelle Thomassin-Naggara (France)
• Clues for a new MR scoring system of uterine mesenchymal tumors – Isabelle Thomassin-Naggara (France)
• A New Era in Endometriosis Diagnosis: Validating SonoPODography for Superficial Endometriosis – Mathew Leonardi (Canada)
• Study Title: Effect of Glucagon-Like Peptide (GLP)-1 Medications on the Management of Endometriosis-Related Symptoms: A Cross-Sectional Survey Study – Mathew Leonardi (Canada)
• Treatment of deep rectal endometriosis with high-intensity focused ultrasounds (HIFU): follow-up at 12 and 24 months (ENDO HIFU FOLLOW-UP study) – Gil Dubernard (France)
• Evaluation of rectal endometriosis treatment with high-intensity focused ultrasound versus surgery: a retrospective multicenter clinical study – Gil Dubernard (France)
• The relationship between expression of selected subpopulations of immune cells in the peritoneal fluid of women with endometriosis – a key role in new therapeutic strategies – Monika Kopec (Poland)
• The truth of M1 and M2 macrophages function and its potential role in gynecological diseases – Monika Kopec (Poland)

10:00 – 12:30
Salle 242

Free Communications 2

• Article title: Effect of Two Different Types of Endometriosis (OMA and DIE) and Their Surgery on Ovarian Reserve: A Large Single-Center, Cross-Sectional Study – Saeed Alborzi (Iran)
• Investigating unilateral ovarian endometrioma’s effect on ova and embryo quality in 409 infertile endometriotic patients – Saeed Alborzi (Iran)
• The effect of vasopressin injection on ovarian reserve in patients with ovarian endometrioma: a randomized controlled trial – Saeed Alborzi (Iran)
• WTAP-mediated m6A modification inhibits fibrosis of endometriosis – Hailan Yan (China)
• Trends in the incidence and DALYs of endometriosis at the global, regional, and national levels from 1990 to 2021 – Hailan Yan (China)
• Does Preimplantation Genetic Testing for Aneuploidy Improved Pregnancy Rates in Recurrent Implantation Failure? A Meta-Analysis of IVF Outcomes – Muhammad Ikhsan (UK)
• A Comparative Study of Menstrual Distress: Insights from Indonesian Populations – Muhammad Ikhsan (UK)
• Plasmacytoid dendritic cells in endometriosis patients – Andrea Knight (Czech Republic)
• Endometriosis, Fibromyalgia, and Autoimmune Diseases: What Are We Missing? – Virginia Manzi (Italy)
• Conservative non-surgical treatment as a feasible option even in case of stenotic bowel endometriosis: long term clinical outcomes and quality-of-life of 580 patients – Silvia Baggio (Italy)
• Subtotal Hysterectomy is Not Inferior to Total Hysterectomy in the Management of Benign Gynecological Diseases – Giacomo Serboli (France)
• Developing a complex ex vivo scaffold free endometrial tissue model using innovative methods – Domitille Le Quéré (France)
• Perceived effectiveness of endometriosis therapies on fatigue: an international survey – Kevin Kuan (Canada)

10:00 – 12:30
Salle 243

Free Communications 3

• EDELWEISS-6: A phase 3 trial assessing the long-term efficacy and safety of Linzagolix versus placebo in women with endometriosis-associated pain – Marie-Madeleine Dolmans (Belgium)
• HOXC6 promotes endometriosis progression via upregulation of IL33 and activation MAPK signaling pathway – Qiutong Li (China)
• Medical treatment in Endometriosis: impact on spontaneous conception and pregnancy outcome – Ernesto Gallucci (Italy)
• Central Sensitization Inventory vs. Other Questionnaires for Nociplastic Pain/Central Sensitization in Endometriosis – Avonae Gentles (Canada)
• Comparison of Adolescent and Young Adult Patients with Endometriosis – Avonae Gentles (Canada)
• Overall usefulness of desogestrel as a safe long-term contraceptive treatment for endometriosis patients: what can we expect? – María-Angeles Martínez-Zamora (Spain)
• Dietary Supplements for Endometriosis-Associated Pain: A Meta-Analysis of Randomized Placebo-Controlled Trials – Noemi Salmeri (Italy)
• Patient-derived organoid models as a promising advanced in vitro model covering crucial genes related to endometriosis-associated dysmenorrhea – Xiaoyan Li (China)
• Prevalence and time interval from symptoms to first hospital diagnosis of young adulthood endometriosis: a French nationwide database study – François Margueritte (France)
• Laparoscopic sclerotherapy for endometrioma during surgery for endometriosis: outcomes in 134 consecutive patients – Adrien Crestani (France)
• Success or failure of surgery for painful endometriosis: Does it depend on the extent of the disease? – Yasmine Drouiche (France)
• Dienogest versus combined oral contraceptive: a systematic review and meta-analysis of efficacy and side effects to inform evidence-based guidelines – Ilaria Piacenti (Italy)
• The Retinol-binding Protein Receptor STRA6 Promotes Adenomyosis Development Regulated by Estradiol – Junting Huang (China)
• The clinical features and long‑term surgical outcomes of diferent types of abdominal wall endometriosis – Yushi Wu (China)

10:00 – 12:30
Salle 220

Free Communications 4

• Characteristics and outcomes in endometrioma infections: a cohort of 94 cases – Guillaume Parpex (France)
• Polymorphism of the 298 Asp eNOS rs1799983 gene in women with glandular endometrial hyperplasia – Bakhodir Kurbanov (Uzbekistan)
• Three-step technique for large endometrioma: a retrospective study – Fien Janssens (Belgium)
• #Enzian classification in adolescents (12-20 years old): ultrasound diagnosis and follow up – Elvira Nocita (Italy)
• Unfreezing the frozen pelvis in deep endometriosis – Sachin Naiknaware (India)
• Lateral distribution of endometriotic lesions: evidence in favor of the retrograde menstruation hypothesis. A systematic review and meta-analysis – Veronica Bandini (Italy)
• Ovarian Steroidogenesis in Women with Endometriosis Undergoing In Vitro Fertilization: A Comparative Analysis of Follicular Fluid Hormonal Profiles – Laura Sichenze (Italy)
• Exploring the molecular mechanisms of metformin in endometriosis: insights into hormonal receptor modulatoin and therapeutic potential – Dinny Sri Utami (Indonesia)
• Ultrasound follow-up of endometriosis in patients on medical and nonmedical therapy using the #Enzian classification (FUP ENZIAN) – Sara Valeriani (Italy)
• The clinical features and surgical outcomes of different types of abdominal wall endometriosis – Menghui Li (China)
• Endometrial assembloids: a novel approach to investigate progesterone resistance – Chloé Beaussart (Belgium)
• A transcriptomics-based computational drug repositioning pipeline identifies simvastatin and primaquine as novel therapeutics for endometriosis pain – Tomiko Oskotsky (USA)

10:00 – 12:30
Salle 221

Free Communications 5

• Endometriosis in Pelvic Inflammatory Disease: A Marker of Complicated Outcomes? – Cristina Ros (Spain)
• The rs2046210 polymorphism is associated with endometriosis risk and elevated ESR1 expression in the eutopic endometrium of women with the disease – Iveta Yotova (Austria)
• Molecular Profiling of Ovarian Endometriosis for for molecular classification and recurrence risk prediction – Carina Masferrer-Ferragutcasas (Spain)
• Spontaneous rupture of endometrioma treated with selective surgery: the recurrence and fertility outcomes after surgery – Zhiyue Gu (China)
• Feasibility and safety of percutaneous ultrasound-guided Polidocanol sclerotherapy for abdominal wall endometriosis – Zhiliang Wang (China)
• The incidence of endometrioma coexisting with other ovarian cysts – Chenyu Zhang (China)
• Endometriosis: primary care in family planning: a pilot project in Belgium – Linda Tebache (Belgium)
• Endometrial alterations after ovarian stimulation: is immediate frozen embryo transfer beneficial? – Vittoria Sterpi (Italy)
• Microbiome dysbiosis and endometriosis: a scoping review of research gaps – Maíra Casalechi (Italy)
• Predicting endometriosis with machine learning: analyzing self-reported data from the Lucy mobile app – Dora Balogh (Hungary)
• The association of endometriosis and endometrial polyps: a systematic review and meta-analysis – Alexander Fiore (Italy)
• Assessment of Endometrial Receptivity Through the Transcriptional Profile of Extracellular Vesicles in Uterine Fluid of Infertile Women – Claudia Ferraro (Italy)
• Can we prevent intrauterine adhesions – Predicting the success of non-surgical management of first trimester retained products of conception using ultrasound parameters – Caroline Mathias (Australia)

10:00 – 12:30
Salle 222

Free Communications 6

• The Endogenesi App: improving quality of life and awareness of endometriosis patients using personalized web app with indications about non pharmacological support and lifestyle changes – Luigi Fasolino (Italy)
• Noninvasive Diagnosis of Endometriosis using Differential Expression Analysis of Circulating miRNAs – Farideh Bischoff (USA)
• Time to Diagnose for Adolescent Endometriosis in West Java, Indonesia Population; A Single Centre 3 Years Cohort Retrospective Study – Widya Maulida (Indonesia)
• Dysmenorrhea: a key symptom in Endometriosis and its overlap with Chronic Inflammatory Bowel Diseases – Federica Iacobini (Italy)
• Challenging the Paradigm: Shared Mechanisms of Estrogen and Progesterone Resistance in Endometriosis and Adenomyosis? – Dian Tjahyadi Mustofa (Indonesia)
• Endometriosis awareness and menstrual Health Initiative for Teenagers (ENDO-HIT) – Raquel Delgado-Gil (Spain)
• Exploring the Interplay Between Endometriosis and Vulvodynia: A Cohort Analysis – Chiara Marra (Italy)
• Assessing the impact of hormone therapies in the endometriosis management: development of a participatory research approach centred on patients and health professionals – Axelle Brulport (France)
• Diverse Risk Factors, Clinical Symptoms, and Tailored Management Approaches on Extrapelvic Endometriosis: Case Series – Amalia Shadrina (Indonesia)
• Improving the Knowledge, Attitude and Health-Seeking Practices on Endometriosis Among Filipino Women with Pelvic Pain Using a Video-Animated Lecture – Riezyl Barbadillo-Culminas (Philippines)

10:00 – 12:30
Salle 223

Free Communications 7

• Laparoscopic hysterectomy and salpingo-oophorectomy versus conservative laparoscopic surgery in women aged 40-50 years old with endometriosis – Samaneh Rokhgireh (Iran)
• Vaginal Bromocriptine and Dienogest on Adenomyosis, which one? – Samaneh Rokhgireh (Iran)
• Linzagolix outcomes in women with concurrent Endometriosis and Adenomyosis: A post-hoc analysis of the EDELWEISS trials – Jacques Donnez (Belgium)
• Long-Term Efficacy and Safety of Linzagolix for Uterine Fibroid Treatment: Results after one year of treatment (extension Study) and up to 6 months following cessation of therapy – Jacques Donnez (Belgium)
• The best endometrial preparation protocol prognosis for FET in adenomyosis women: sistematic review – Ni Luh Lany Christina Prajawati (Indonesia)
• HRT, Gnrha down-regulation, and Oxytocin Antagonist Prognosis as the best endometrial Preparation for FET in Adenomyosis Women – Ni Luh Lany Christina Prajawati (Indonesia)
• Linzagolix Rapidly Reduces Heavy Menstrual Bleeding in Women with Uterine Fibroids: A post-hoc analysis of the PRIMROSE trials – Felice Petraglia (Italy)
• Improvement in haemoglobin and other anaemia/iron deficiency biomarkers in women with uterine fibroids and anaemia treated with linzagolix versus placebo: a post-hoc analysis of the PRIMROSE trials – Felice Petraglia (Italy)
• Frozen Embryo Transfer Outcomes Differences in Adenomyosis Patients with or without GnRH agonist Downregulation – 7 Years of Retrospective Cohort Study – Alfonsus Zeus Suryawan (Indonesia)
• How common are hormonal treatments in patients later undergoing surgery for Uterine Fibroids? – Flavia Sorbi (Italy)
• Extrinsic Adenomyosis Is Associated with Higher Infertility Rates Compared to Intrinsic Adenomyosis: A Single-Center Retrospective Study – Georgios Kolovos (Switzerland)

10:00 – 12:30
Salle 224

Free Communications 8

• Symptom recurrence after discontinuation of dienogest treatment of adenomyosis – Xishi Liu (China)
• Pregnancy outcomes in adenomyosis and correlation with ENZIAN scores – Titia Van Iperen (The Nethelands)
• An experiental management of repeated implantation failures in women having adenomyosis – Nhut Luan Au (Vietnam)
• Incidence of uterine leiomyomata among women over 40: A population-based prospective cohort study – Sara Hachem (France)
• Adenomyosis associated with Endometrial Cancer: possible correlation with pathological, immunohistochemical and molecular characteristics – Francesco La Torre (Italy)
• Influence of mixed cell zones diversity on the pathophysiology of adenomyosis endothelium discovered by spatial transcriptome-based technology – Zhang Jing (China)
• Efficacy of Uterine Artery Embolization in the Management of Uterine Adenomyosis – Kavitha Kovi (India)
• The role of simvastation 20mg on suppresing uterine fibroid size: a clinical study in Indonesia – Muhammad Ernesto Azguevara Ganis Siregar (Indonesia)
• Mechanisms of metformin on adenomyosis – Yohanes Iddo Adventa (Indonesia)
• Association of self-reported race and genomic ancestry makers with fibrosis severity in uterine leiomyomas – Fernando Reis (Brazil)
• Adenomyosis: role of imaging for the diagnosis and monitoring of medical treatment – Aurora Padelli (Italy)
• What are the key differences between Adenomyosis and Endometriosis in terms of Pathogenesis: A Literature Review – Muhammad Alif (Indonesia)
• Transitional lesions”, a step further in understanding the pathogenesis of adenomyosis – Alessandra Camponi (Belgium)

10:00 – 12:30
Salle 244

Free Communications 9

• The difference impact between conservative surgical treatment and non-surgical treatment of adenomyosis on IVF outcome – Anna Theresia Regina Ritonga (Indonesia)
• Impact of patient blood management program on myomectomy surgery in Saint-Joseph Hospital (Paris) – Louis Roucaute (France)
• Effects of angiotensin-(1-7) on uterine leiomyoma fragments in vitro – Elaine Sousa Francisco (Brazil)
• Role of Ferritin and GPx4 as Ferroptosis Marker in Adenomyosis – David Halim (Indonesia)
• Preconceptional laparoscopic cerclage for prevention of preterm birth: a systematic review – Dimitrios Rafail Kalaitzopoulos (Switzerland)
• Eliminating NARCotic prescriptions from Outpatient minimally invasive gynecologic Surgery (eNARCOS): a randomized controlled trial – Jade Desilets (Canada)
• Analysing “Dr Sachin’s Criteria” for adnexal torsion management – Sachin Naiknaware (India)
• From Reactive to Proactive: Leveraging AI for Preventive Gynecological and Fertility Care – Jerome Bouaziz (France)
• Impact of Surgeon Expertise on Long-Term Outcomes in Ovarian Endometrioma Rupture Cases: Specialist VS Non-specialist Comparison – Shiqing Lyu (China)
• Use and Effectiveness of Complementary Therapies for Endometriosis: Patients’ Experiences – Federico Toscano (Italy)
• Exploring altered glucose metabolism and insulin sensitivity in extra-ovarian endometrioss: insights from gene expression profiling – Gianfranco Fornelli (Italy)
• The association between endometriosis and benign uterine disorders: insights from an observational matched case-control study – Gianfranco Fornelli (Italy)

10:00 – 12:30
Salle 245

Free Communications 10

• A Rare Case of Vaginal Leiomyoma Presenting as a Perineal Mass: Clinical and Surgical Implications – Giovana Da Gama Fortunato (Brazil)
• Giant Mucinous Cystadenoma of the Ovary – Clinical and Surgical Approach – Giovana Da Gama Fortunato (Brazil)
• Clitoromegaly secondary to congenital adrenal hyperplasia – Case Report – Giovana Da Gama Fortunato (Brazil)
• Congenital adrenal hyperplasia and genital ambiguity: the role of a multidisciplinary approach in therapeutic management – Giovana Da Gama Fortunato (Brazil)
• Chemotherapy-induced diminished murine ovarian reserve model and impact of low-dose chemotherapy on fertility – Lara Houeis (Belgium)
• Obstructed hemivagina and ipsilateral renal anomaly (OHVIRA) syndrome: A case series – Brianna Cloke (UK)
• Menopausal Symptom Characterisation among Sri Lankan Women: MARIE-Sri Lanka (WP2a) Interim Analysis – Pradeep Mitra (Sri Lanka)
• The role of catastrophizing in women with endometriosis-related chronic pelvic pain: a moderated mediation model – Maria Federica Viscardi (Italy)
• Ultrasound-guided uterosacral ligament anesthetic block – Angelo Votino (Italy)
• Endometriosis and Vulvodynia: A Shared Burden of Chronic Pain – Angela Gallone (Italy)

10:00 – 12:30
Salle 246

Free Communications 11

• Detection of PID-related adhesions with transvaginal ultrasonography – Mathew Leonardi (Canada)
• Robotic High Intensity Focused Ultrasoud treatment of rectal endometriosis – Gil Dubernard (France)
• Laparoscopic Identification of the Inferior Hypogastric Nerve for the Gynecologist – Georgios Grigoriadis (Greece)
• Surgical Technique of Laparoscopic Mesh-less Pectopexy for Uterine Prolapse – Georgios Grigoriadis (Greece)
• Enhancing Safety in Deep Endometriosis Surgery of the Parametrium Region: Lateral Approach Using Umbilical Artery Guidance, Prior Vascular Control, and Ureterolysis for Ureteral Encasement – Luccas Chagas (Brazil)
• Laparoscopic En Bloc NOSE Resection of Cecum, Rectum, Sigmoid, Bladder, Vagina, and Ileum for Severe Endometriosis After Hysterectomy – Luccas Chagas (Brazil)
• Stepwise Approach to Improving Hemostasis in Laparoscopic Assisted Mini-laparotomy Myomectomy – Michael Suen (Canada)
• Total laparoscopic vascular-sparing segmental bowel resection for rectal endometriosis – Zhijun Hu (China)
• An unusal case of ’frozen pelvis’ encountered in Endometriosis Center – Hong-Yuan Jiang (China)
• Laparoscopic shaving and discoid excision of bowel endometriosis – Rok Šumak (Slovenia)
• Modified approach in congenital cervical and vaginal agenesis(C4V4) with endometriosis – Hexia Xia (China)
• Laparoscopic Treatment of a Rare and Widely Disseminated Pelvic Endometriotic Cyst – Jingsong Yi (China)
• Endometrial Tuberculosis and Infertility: A Complex Challenge in Indonesia(Video Presentation) – Agus Heriyanto (Indonesia)

10:00 – 12:30

Plenary Room A

Attila Bokor (Hungary), Marcello Ceccaroni (Italy), Herve Fernandez (France), Lubomir Mikulasek (Czech Republic), Filipa Osorio (Portugal), Helder Ferreira (Portugal) & Michael Mueller (Switzerland)

12:30 – 13:00

Plenary Room A

• Prevention of uterine fibroids – Ayman Al-Hendy (USA)

13:00 – 14:00
Exhibition Hall

13:15 – 14:15

Plenary Room A

• Welcome and Introduction – Marie-Madeleine Dolmans (Belgium)
• Challenges in Uterine Fibroid Management and Recent Advances in Pharmacological Treatments – Felice Petraglia (Italy)
• Real-World Case 1: Management of troublesome Heavy Menstrual Bleeding in a Uterine Fibroid patient – Mariona Rius (Spain)
• Real-World Case 2: Fibroid Volume reduction in a Uterine Fibroid patient – Francois Closon (Belgium)
• Panel Discussion: Q&A from the Audience, Faculty

14:15 – 15:45

Plenary Room A

• Role of genetic and epigenetic –Sun-Wei Guo (China)
• Impact of sex steroid hormones from adolescence to menopause – Paola Vigano (Italy)
• Inflammatory comorbidities: where they come from? Maxime Jeljeli (USA)
• Is endometriosis a progressive disease? Carla Tommasetti (Belgium)

14:15 – 15:45

Plenary Room B

• Health consequences of type and age of menopause in women with endometriosis – Genevieve Plu-Bureau (France)
• From estrogens to no estrogens: what to expect in QoL and future health? Rossella Nappi (Italy)
• Decision-making in the hormonal management of symptomatic postmenopausal women with uterine benign conditions/endometriosis – Ludwig Kiesel (Germany)
• Non hormonal approach in treating vasomotor symptoms and other QoLvariables – Antonio Cano (Spain)

15:45 – 16:45

Plenary Room A

• Why early endometriosis diagnosis is essential? Silvia Vannuccini (Italy)
• Is severe dysmenorrhea always synonymous of endometriosis? Michael Mueller (Switzerland)
• Role of Biomarkers in the diagnosis of superficial endometriosis – Gaby Moawad (USA)
• Q&A – All of the experts
• Modern Endometriosis Diagnosis : Key Answers – Charles Chapron (France)

15:45 – 16:45

Plenary Room B

16:45 – 17:15
Exhibition Hall

17:15 – 18:45

17:15 – 18:00

Plenary Room A

Debate 1 – Recurrence after endometriosis surgery: Is it a real risk?
Chair: Sun-Wei Guo (China)
Michael Mueller (Switzerland) VS Jacques Donnez (Belgium)

17:15 – 18:00

Plenary Room B

Debate 2 – Hormonal treatments for benign diseases in BRCA positive women: is there a risk?
Chair: Rossella Nappi (Italy)
Ludwig Kiesel (Germany) VS Paul Yong (Canada)

18:00 – 18:45

Plenary Room A

Debate 3 – Ultrasound vs hysteroscopy in menopausal AUB
Chair: Roberto Tozzi (Italy)
Stefano Bettocchi (Italy) VS Daniela Fischerova (Czech Republic)

18:00 – 18:45

Plenary Room B

Debate 4 – ART or myomectomy for infertile patients with uterine fibroids?
Chair: Fernando Reis (Brazil)
Mathilde Bourdon (France) VS Francisco Carmona (Spain)

20:00

08:30

09:00 – 10:30

Plenary Room A

• The junctional zone – Joel Naftalin (UK)
• Is adenomyosis an infertility disorder? Tevfik Yoldemir (Turkey)
• Deep endometriosis: common of different entities? Francisco Carmona (Spain)
• Respective place of surgery and ART for infertile patients – Pietro Santulli (France)

09:00 – 10:30

Plenary Room B

• Decoding the mechanisms of uterine fibroid-related bleeding and infertility – Jacques Donnez (Belgium)
• Molecular Genetics of the origin of uterine fibroids – Mohamed Ali (USA)
• Ultrasound findings in infertile women with adenomyosis and concomitant uterine disorders – Caterina Exacoustos (Italy)
• Modelling adenomyosis with organoids – Marie-Madeleine Dolmans (Belgium)

10:30 – 11:00
Exhibition Hall

11:00 – 11:30

Plenary Room A

• Carcinomas arising in the setting of endometriosis – Xavier Matias Guiu (Spain)

11:30 – 13:00

Plenary Room A

• Importance of the periconceptional counselling – Pavel Calda (Czech Republic)
• Early pregnancy complications – Blazej Meczekalski (Poland)
• Role of the Junctional Zone in gestational disorders – Mariona Rius (Spain)
• Placenta accreta spectrum in women with uterine disorders – Alvaro Nieto (Colombia)

13:00 – 13:30

Plenary Room A

SEUD Grant research 2024
SEUD Grant research 2025

13:30 – 14:00

Plenary Room A

SEUD President: Francisco Carmona (Spain)
Congress President: Lubomir Mikulasek (Czech Republic)